|
|
Adderall (Amphetamine-Dextroamphetamine)
|
 |
Central nervous system agent
|
 |
Central nervous system stimulant
|
 |
Narcolepsy: Adults 5 to 60 mg a day, 1 to 3 times a day and not to exceed 60 mg daily. Teenagers: Initial treatment, 10 mg a day. Children ages 6 to 12: Initial treatment, 5 mg a day. ADHD in children ages 6 and older: Initial treatment, 5 mg, 1 or 2 times daily. Children ages 3 to 6: Initial treatment, 2.5 mg daily.
|
 |
Category C
|
 |
Insomnia, restlessness, mood changes, dry mouth, unpleasant taste, Constipation, nausea, vomiting, changes in sexual desire or decreased sexual activity.
|
Pregnancy Risk Categories defined:
A: Studies in pregnant women failed to show a risk to the fetus in the first
trimester - with no evidence of risk in the later trimesters.
B: Animals studies indicate no adverse effect to the fetus, but there are no adequate,
clinical studies in pregnant women.
C: Animal studies have shown an adverse effect on the fetus, but there are no adequate,
clinical studies in humans. Despite potential risks, the drug may be useful in pregnant
women.
D: There is evidence of risk to the human fetus, but the potential benefits of use in
pregnant women may be acceptable, despite potential risks.
X: Studies in animals or humans show fetal abnormalities, or adverse reaction reports
indicate evidence of fetal risk. Warning: the risks involved clearly outweigh any
potential benefit from using the drug in pregnant women, regardless of trimester.
NR: Not rated (i.e., no information available at this time as to the potential
risks or benefits).
|
| | |
If you want your friend to read or know about this article, Click here
 |
|
|
